| Ms Mary Elizabeth Giamartino, RPH | |
|
20 Elliot St, Suite 1, Brattleboro, VT 05301-3208 | |
| (802) 254-2303 | |
| (802) 257-0023 |
| Full Name | Ms Mary Elizabeth Giamartino |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 20 Elliot St, Brattleboro, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629116918 | NPI | - | NPPES |
| 0380000565 | Other | VT | RETAIL PHARMACY LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 0330002621 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Mary Elizabeth Giamartino, RPH 20 Elliot St, Suite 1, Brattleboro, VT 05301-3208 Ph: (802) 254-2303 | Ms Mary Elizabeth Giamartino, RPH 20 Elliot St, Suite 1, Brattleboro, VT 05301-3208 Ph: (802) 254-2303 |
News Archive
Marked by acute temporary confusion, disorientation and/or agitation, postoperative delirium is the most common post-surgical complication in older adults, striking as many as half of adults older than 65 who undergo high-risk procedures such as cardiac surgery or hip replacements.
Prior Scientific, a leader in advanced high precision microscopy products, details its extensive range of automated systems, motorised stages and accessories for neuroscience and electrophysiological applications in a new brochure.
Onconova Therapeutics, Inc. today announced positive human safety, tolerability, and pharmacokinetic data from three clinical trials of Ex-RAD (recilisib sodium, ON 01210.Na), a novel radioprotectant being developed as a medical countermeasure for the treatment of acute radiation syndrome (ARS).
"Worldwide, evidence-based interventions are being implemented in an effort to drive down child mortality and there are some signs that they are working," a Lancet editorial states. "However, few countries are on course to meet the targets set by Millennium Development Goal 4," the editorial notes.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for the company's Investigational Device Exemption (IDE) to conduct a human clinical trial for its BioFoam® Surgical Matrix protein hydrogel technology.
› Verified 5 days ago
Mr. Andrew Chapman Miller, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 499 Canal Street, Brooks Pharmacy # 605, Brattleboro, VT 05301 Phone: 802-257-4204 Fax: 802-257-4766 | |
Maria L Schwarz, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 896 Putney Rd Ste 25, Brattleboro, VT 05301 Phone: 802-257-5592 | |
Mr. Scott Thomas Motyka, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 413 Canal St, Brattleboro, VT 05301 Phone: 802-254-7777 Fax: 802-254-8444 | |
Mrs. Howen Chao, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 467 Canal St, Brattleboro, VT 05301 Phone: 802-254-5633 Fax: 802-254-6167 | |
Mrs. Susan Harris, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Anna Marsh Lane, Brattleboro, VT 05302 Phone: 802-257-7785 | |
Anne Daly, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 896 Putney Rd, Brattleboro, VT 05301 Phone: 802-257-5592 | |
Dr. Casey Powers, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 Elliot St, Brattleboro, VT 05301 Phone: 802-254-2303 Fax: 802-257-0023 |